Gene: NFRKB
Official Full Name: nuclear factor related to kappaB binding proteinprovided by HGNC
Gene Summary: Enables protease binding activity. Involved in several processes, including chromatin remodeling; regulation of chromosome organization; and regulation of nucleobase-containing compound metabolic process. Located in Ino80 complex and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36341 | NFRKB Knockout cell line (HeLa) | Human | NFRKB | 1:3~1:6 | Negative | Online Inquiry |
KO36342 | NFRKB Knockout cell line (HCT 116) | Human | NFRKB | 1:2~1:4 | Negative | Online Inquiry |
KO36343 | NFRKB Knockout cell line (HEK293) | Human | NFRKB | 1:3~1:6 | Negative | Online Inquiry |
NFRKB Gene Knockout Cell Lines are specifically engineered cellular models designed to eliminate the expression of the Nuclear Factor Related to kappa-B (NFRKB) gene. This targeted gene disruption is achieved through advanced CRISPR/Cas9 genome-editing technology, which allows for precise modifications at the genomic level. By knocking out NFRKB, these cell lines enable researchers to investigate the gene's role in cellular processes, including immune response, inflammation, and cellular proliferation.
The primary function of NFRKB involves transcribing genes related to the inflammatory response and immune system regulation. By using NFRKB knockout cell lines, scientists can examine the resultant phenotypes and delineate the pathways influenced by this gene. Researchers can explore various biological responses—such as cytokine production, cell cycle regulation, and apoptosis—affording insights into disease mechanisms and therapeutic targets.
The scientific importance of these cell lines is profound, particularly in the realms of cancer research and autoimmune diseases. They provide a versatile platform for drug discovery and validation, allowing researchers to evaluate the efficacy of potential therapeutics in a genetically defined context. In clinical research, understanding the modulation of NFRKB pathways can facilitate the development of targeted therapies that could improve patient outcomes.
What sets our NFRKB Gene Knockout Cell Lines apart from alternative products is the high specificity and efficiency of the knockout profiles, validated through rigorous genomic analysis and functional assays. Additionally, our cell lines are made available in various backgrounds, accommodating a wide range of experimental conditions and research needs.
For researchers and clinicians, the value of these knockout cell lines lies in their ability to provide a clear view into the functional implications of NFRKB gene loss, reducing the ambiguity often associated with pharmacological inhibition. By offering these robust tools, our company leverages years of expertise in molecular biology and genetics to support advancements in biomedical research, ensuring that our products meet the highest standards of quality and reliability in the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.